Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer - Male”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01588821
What this trial is testing

Cabozantinib in Advanced Solid Malignancies

Who this might be right for
Lung CancerSolid Tumor (Not Breast or Prostate Cancers)
Massachusetts General Hospital 37
Testing effectiveness (Phase 2)Study completedNCT03518606
What this trial is testing

Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumoursBreast CancerHead and Neck Cancer+2 more
UNICANCER 126
Testing effectiveness (Phase 2)Study completedNCT00059852
What this trial is testing

Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 61
Not applicableStudy completedNCT01015963
What this trial is testing

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 69
Not applicableUnknownNCT01801852
What this trial is testing

Autologous Natural Killer T Cells Infusion for the Treatment of Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Chinese PLA General Hospital 300
Early research (Phase 1)Study completedNCT00703638
What this trial is testing

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 16
Not applicableUnknownNCT05227898
What this trial is testing

Virtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With Cancer

Who this might be right for
Cancer
Blue Note Therapeutics 352
Not applicableLooking for participantsNCT07741435
What this trial is testing

Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia

Who this might be right for
NeoplasmsSolid TumorBreast Neoplasms+8 more
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo 3,250
Not applicableLooking for participantsNCT07416630
What this trial is testing

Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

Who this might be right for
Gynecologic CancerUrologic CancerBreast Cancer
Institute of Oncology Ljubljana 30
Not applicableNo Longer AvailableNCT03554434
What this trial is testing

An Expanded Access Program for AM0010 (Pegilodecakin)

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT01355393
What this trial is testing

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+5 more
University of Washington 50
Not applicableStudy completedNCT03816904
What this trial is testing

Involvement of SK3 Calcium Channel in Taxane Neuropathy

Who this might be right for
Breast CancerChemotherapy-induced Peripheral NeuropathyProstate Cancer
University Hospital, Tours 97
Not applicableStudy completedNCT01611038
What this trial is testing

Methylselenocysteine Effects on Circadian Rhythm

Who this might be right for
Breast CancerProstate Cancer
Rutgers, The State University of New Jersey 100
Not applicableEnrolling By InvitationNCT06885424
What this trial is testing

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

Who this might be right for
Solid Tumor CancerSolid Tumor, Unspecified, AdultColorectal Carcinoma+12 more
A2 Biotherapeutics Inc. 400
Early research (Phase 1)Study completedNCT05578820
What this trial is testing

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Who this might be right for
SarcomaMelanomaSquamous Cell Carcinoma of Head and Neck+5 more
Gene Surgery LLC 21
Not applicableLooking for participantsNCT07231159
What this trial is testing

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Who this might be right for
Breast CancerLung Cancer (Diagnosis)Prostate Cancer
AdventHealth 200
Not applicableEnded earlyNCT04436120
What this trial is testing

Treatment Resistance Following Anti-cancer Therapies

Who this might be right for
Disease Progression
Pfizer 38
Not applicableStudy completedNCT04000880
What this trial is testing

Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health

Who this might be right for
Breast CancerColorectal CancerEndometrial Cancer+6 more
University of Alabama at Birmingham 603
Not applicableStudy completedNCT00974610
What this trial is testing

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Cancer Trials Ireland 803
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Next Page